Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
33638 Results Found
Triple Aim Strategies to Integrate Behavioral Health in Primary Care
There is a growing need to improve health care, especially at the interface between general medicine and mental health and substance abuse.
Hospital and Health System Leaders Discuss the Impact of Coordinated Care and Connected Health
The challenge of aligning with government payment models often hampers progress, but alternate care systems have potential to ally incentives and coordinate care, which could dramatically reduce costs.
AHA: Hospitals Are Leading Transformation
"In times of disasters, outbreaks and tragedies, communities lean on their hospitals: That fact will never change."
CMS Approves Third Medicaid Waiver with Work Requirement
The Centers for Medicare & Medicaid Services today approved a waiver for Arkansas that will require some adult beneficiaries under age 50 to work or participate in job training, community service or other “community engagement” activities.
AHA Op-ed: Site-neutral Payment Proposals Threaten Access to Care
A recent opinion piece in The Hill “gives readers a one-sided, misleading and misinformed view on the issue of site-neutral payment proposals and consolidation in the health field.”
AHA Comments on Proposed MA, Part D Payment Policies for 2019
AHA voiced strong support for the Centers for Medicare & Medicaid Services’ proposal to expand the types of supplemental benefits that MA plans can offer to better manage beneficiary health.
Expanding Pediatric Mental Health Services in the Face of a Workforce Shortage
Held December 7, 2016
CMS Announces QPP Measure Development Funding Opportunity
The Centers for Medicare & Medicaid Services is accepting applications through May 2 for up to $30 million in cooperative agreements to develop, improve, update or expand quality measures under the Quality Payment Program for clinicians.
FDA: Don’t Use Cantrell Compounded Drug Products
The Food and Drug Administration yesterday alerted health care professionals and patients not to use drug products produced by Cantrell Drug Co., including opioid products and other drugs intended for sterile injection, citing serious deficiencies in the company’s compounding operations.